This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by von Eckardstein, A. Articles by Assmann, G. Search for Related Content PubMed PubMed Citation Articles by von Eckardstein, A. Articles by Assmann, G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:691-703.)
© 1995 American Heart Association, Inc.

Articles

Reverse Cholesterol Transport in Plasma of Patients With Different Forms of Familial HDL Deficiency

Arnold von Eckardstein; Yadong Huang; Shili Wu; Harald Funke; Giorgio Noseda; Gerd Assmann

From the Institut für Klinische Chemie und Laboratoriumsmedizin, Zentrallaboratorium, Westfälische Wilhelms-Universität (A. von E., H.F., G.A.), and the Institut für Arterioskleroseforschung an der Universität Münster (Y.H., S.W., G.A.), Münster, FRG, and the Ospedale Regionale della Beata Vergine, CH-Mendrisio, Switzerland (G.N.).

Correspondence to Arnold von Eckardstein, Institut für Klinische Chemie und Laboratoriumsmedizin, Zentrallaboratorium, Westfälische Wilhelms-Universität, Albert-Schweitzer-Strasse 33, D-48129 Münster FRG.

Abstract HDLs encompass structurally heterogenous lipoproteins that fulfill specific functions in reverse cholesterol transport. Two-dimensional nondenaturing gradient gel electrophoresis (2D-PAGGE) of normoalphalipoproteinemic plasma and subsequent immunoblotting with anti–apoA-I-antibodies differentiates pre-ß₁-LpA-I, pre-ß₂-LpA-I, pre-ß₃-LpA-I, -LpA-I₂, and -LpA-I₃. Immunodetection with anti-apoE antibodies differentiates -LpE and -LpE. Pulse-chase incubations of plasma with [³H]unesterified cholesterol ([³H]UC)–labeled fibroblasts and subsequent 2D-PAGGE revealed that cell-derived [³H]UC is taken up by pre-ß₁-LpA-I and -LpE. From these initial acceptors, [³H]UC is transferred to LDL via pre-ß₂-LpA-Ipre-ß₃-LpA-I-LpA-I. Some UC is esterified in pre-ß₃-LpA-I, and some is esterified in -LpA-I after its retransfer from LDL. In this study we investigated the effect of various forms of familial HDL deficiency on reverse cholesterol transport. Plasma samples of patients with various forms of HDL deficiency are characterized by the lack of specific HDL subclasses. ApoE-containing HDLs, including -LpE, are present in all kinds of HDL deficiency. However, all forms of LpA-I are absent in apoA-I–deficient plasma, pre-ß₃-LpA-I and -LpA-I from the plasma of patients with Tangier disease (TD), and pre-ß₃-LpA-I and large -LpA-I from the plasma of patients with lecithin:cholesterol acyltransferase (LCAT) deficiency and fish-eye disease (FED). After a 1-minute pulse with labeled fibroblasts, efflux of [³H]UC into HDL-deficient plasmas decreased, compared with normal plasma, by 49% (apoA-I deficiency), 36% (TD), 21% (LCAT deficiency), and 28% (FED). In apoA-I deficiency, only -LpE takes up cell-derived [³H]UC. In the three other HDL-deficiency states, cell-derived [³H]UC is initially taken up by both pre-ß₁-LpA-I and -LpE. The four HDL deficiencies are also characterized by differences in the esterification of cell-derived [³H]UC. No esterification occurs in LCAT-deficient plasma. In FED plasma, [³H]UC is esterified in LDL. In apoA-I deficiency and TD, however, [³H]UC is esterified in lipoproteins free of apoA-I and apoB. In the two latter cases, the transfer of [³H]cholesteryl ester to LDL is enhanced compared with normal plasma. The lack of specific HDL subclasses and the consequent changes in reverse cholesterol transport pathways differently affect net mass efflux of cholesterol from fibroblasts into HDL-deficient plasma. Compared with normoalphalipoproteinemic plasma, net cholesterol efflux from fibroblasts into plasma is reduced by 48%, 12%, 60%, and 34% in apoA-I deficiency, TD, LCAT deficiency, and FED, respectively. Removal of apoB-containing lipoproteins from plasma of patients with apoA-I deficiency, TD, LCAT deficiency, and FED further decreased net cholesterol efflux rates by 77%, 84%, 72%, and 64%, respectively, compared with a reduction of 39% in normoalphalipoproteinemic control plasma. In conclusion, various quantitatively minor HDL subfractions and LDL also present in HDL-deficient plasma effectively contribute to reverse cholesterol transport.

Key Words: HDL subclasses • apoA-I deficiency • familial LCAT deficiency • fish-eye disease • Tangier disease

This article has been cited by other articles:

				M. Nishiwaki, K. Ikewaki, G. Bader, H. Nazih, M. Hannuksela, A. T. Remaley, R. D. Shamburek, and H. B. Brewer Jr Human Lecithin:Cholesterol Acyltransferase Deficiency: In Vivo Kinetics of Low-Density Lipoprotein and Lipoprotein-X Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1370 - 1375. [Abstract] [Full Text] [PDF]

				J. F. Oram and J. W. Heinecke ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease Physiol Rev, October 1, 2005; 85(4): 1343 - 1372. [Abstract] [Full Text] [PDF]

				L. Krimbou, H. Hajj Hassan, S. Blain, S. Rashid, M. Denis, M. Marcil, and J. Genest Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines J. Lipid Res., August 1, 2005; 46(8): 1668 - 1677. [Abstract] [Full Text] [PDF]

				H. Hajj Hassan, S. Blain, B. Boucher, M. Denis, L. Krimbou, and J. Genest Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release J. Lipid Res., July 1, 2005; 46(7): 1457 - 1465. [Abstract] [Full Text] [PDF]

				D. M. Selva, V. Hirsch-Reinshagen, B. Burgess, S. Zhou, J. Chan, S. McIsaac, M. R. Hayden, G. L. Hammond, A. W. Vogl, and C. L. Wellington The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility J. Lipid Res., June 1, 2004; 45(6): 1040 - 1050. [Abstract] [Full Text] [PDF]

				L. Krimbou, M. Denis, B. Haidar, M. Carrier, M. Marcil, and J. Genest Jr. Molecular interactions between apoE and ABCA1: impact on apoE lipidation J. Lipid Res., May 1, 2004; 45(5): 839 - 848. [Abstract] [Full Text] [PDF]

				G Kolovou, D Daskalova, K Anagnostopoulou, I Hoursalas, V Voudris, D P Mikhailidis, and D V Cokkinos Postprandial hypertriglyceridaemia in patients with Tangier disease J. Clin. Pathol., December 1, 2003; 56(12): 937 - 941. [Abstract] [Full Text] [PDF]

				L. Krimbou, M. Marcil, H. Chiba, and J. Genest Jr. Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles J. Lipid Res., May 1, 2003; 44(5): 884 - 892. [Abstract] [Full Text] [PDF]

				P. C. R. Hopkins, Y. Huang, J. G. McGuire, and R. E. Pitas Evidence for differential effects of apoE3 and apoE4 on HDL metabolism J. Lipid Res., November 1, 2002; 43(11): 1881 - 1889. [Abstract] [Full Text] [PDF]

				M. Lee, L. Calabresi, G. Chiesa, G. Franceschini, and P. T. Kovanen Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I-Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular Cholesterol Efflux Arterioscler Thromb Vasc Biol, September 1, 2002; 22(9): 1475 - 1481. [Abstract] [Full Text] [PDF]

				N. Fournier, V. Atger, J.-L. Paul, M. Sturm, N. Duverger, G. H. Rothblat, and N. Moatti Human ApoA-IV Overexpression in Transgenic Mice Induces cAMP-Stimulated Cholesterol Efflux From J774 Macrophages to Whole Serum Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1283 - 1292. [Abstract] [Full Text] [PDF]

				M. N. Nanjee and E. A. Brinton Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography Clin. Chem., February 1, 2000; 46(2): 207 - 223. [Abstract] [Full Text] [PDF]

				A. Davit-Spraul, V. Atger, M. L. Pourci, M. Hadchouel, A. Legrand, and N. Moatti Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome: importance of the HDL-phospholipids/free cholesterol ratio and of the HDL size distribution J. Lipid Res., February 1, 1999; 40(2): 328 - 335. [Abstract] [Full Text]

				M. Miller, D. Aiello, H. Pritchard, G. Friel, and K. Zeller Apolipoprotein A-IZavalla (Leu159->Pro) : HDL Cholesterol Deficiency in a Kindred Associated With Premature Coronary Artery Disease Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1242 - 1247. [Abstract] [Full Text] [PDF]

				Y. Zhu, S. Bellosta, C. Langer, F. Bernini, R. E. Pitas, R. W. Mahley, G. Assmann, and A. von Eckardstein Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma PNAS, June 23, 1998; 95(13): 7585 - 7590. [Abstract] [Full Text] [PDF]

				A. von Eckardstein, A. Chirazi, S. Schuler-Lüttmann, M. Walter, J. J. P. Kastelein, J. Geisel, J. T. Real, R. Miccoli, G. Noseda, G. Höbbel, et al. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I J. Lipid Res., May 1, 1998; 39(5): 987 - 998. [Abstract] [Full Text]

				Y. Huang, Y. Zhu, C. Langer, M. Raabe, S. Wu, B. Wiesenhutter, U. Seedorf, N. Maeda, G. Assmann, and A. von Eckardstein Effects of Genotype and Diet on Cholesterol Efflux into Plasma and Lipoproteins of Normal, Apolipoprotein A-I-, and Apolipoprotein E-Deficient Mice Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2010 - 2019. [Abstract] [Full Text]

				F. Blanco-Vaca, S.-J. Qu, C. Fiol, H.-Z. Fan, Q. Pao, A. Marzal-Casacuberta, J. J. Albers, I. Hurtado, V. Gracia, X. Pinto, et al. Molecular Basis of Fish-Eye Disease in a Patient From Spain : Characterization of a Novel Mutation in the LCAT Gene and Lipid Analysis of the Cornea Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1382 - 1391. [Abstract] [Full Text]

				D. S. Ng, O. L. Francone, T. M. Forte, J. Zhang, M. Haghpassand, and E. M. Rubin Disruption of the Murine Lecithin:Cholesterol Acyltransferase Gene Causes Impairment of Adrenal Lipid Delivery and Up-regulation of Scavenger Receptor Class B Type I J. Biol. Chem., June 20, 1997; 272(25): 15777 - 15781. [Abstract] [Full Text] [PDF]

				J. S. Cohn, M. Tremblay, M. Amiot, D. Bouthillier, M. Roy, J. Genest Jr, and J. Davignon Plasma Concentration of Apolipoprotein E in Intermediate-Sized Remnant-Like Lipoproteins in Normolipidemic and Hyperlipidemic Subjects Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 149 - 159. [Abstract] [Full Text]

				Y. Huang, A. von Eckardstein, S. Wu, C. Langer, and G. Assmann Generation of Pre-ß1-HDL and Conversion Into {alpha}-HDL : Evidence for Disturbed HDL Conversion in Tangier Disease Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1746 - 1754. [Abstract] [Full Text]

				A. von Eckardstein, Y. Huang, S. Wu, A. S. Sarmadi, S. Schwarz, A. Steinmetz, and G. Assmann Lipoproteins Containing Apolipoprotein A-IV but Not Apolipoprotein A-I Take Up and Esterify Cell-Derived Cholesterol in Plasma Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1755 - 1763. [Abstract] [Full Text]

				Y. Huang, A. von Eckardstein, S. Wu, and G. Assmann Cholesterol Efflux, Cholesterol Esterification, and Cholesteryl Ester Transfer by LpA-I and LpA-I/A-II in Native Plasma Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1412 - 1418. [Abstract] [Full Text]